Leumas, a deeptech manufacturing startup, has raised $2.2 million in its seed funding round led by Capital 2B, a deeptech-focused fund backed by Info Edge and Temasek. The round also saw participation from Capital-A and Anicut Capital.
The fresh funds raised will be used to expand its R&D capabilities, scale its on-demand manufacturing infrastructure, and launch pilot deployments of dedicated factories for wellness and pharma brands.
Founded in 2016 by Subhajit Biswas and Nitesh K, Leumas is a deep-tech manufacturing startup building modular, software-driven robot factories for wellness and pharma brands. Its offerings include on-demand manufacturing services and dedicated factory solutions with flexible, pay-per-use, or fully managed factory models. By combining automation, software intelligence, and R&D, Leumas helps brands scale quickly, maintain quality, and reduce risk.
These asset-light and intelligent manufacturing lines support formulation development, pilot-scale production, and commercial manufacturing with greater speed, flexibility, and precision.
Leumas addresses this emerging USD 100+ billion opportunity by offering on-demand manufacturing and factory-as-a-service models for wellness and pharma brands. Its solution is built on software-defined, modular robot factories that radically improve manufacturing and business outcomes – from development to commercial production.
Leumas’ core innovation is its cyber-physical manufacturing technology: software-driven, modular production lines that integrate AI-led robotics, vision-based quality systems, and autonomous operations to ensure optimal production output and regulatory compliance.
Over the past year, Leumas has co-developed its manufacturing solution with leading wellness brands and has helped scale more than 120 products across India, the US, and MENA. It has also signed agreements with prominent pharma and food research institutions to build dedicated factory capacities using its modular factory solution.
Subhajit Biswas and Nitesh K, Co-Founders of Leumas, said, “Pharma and wellness brands today need more than just capacity. They need agility, traceability, and the ability to scale without being restricted by outdated infrastructure. We are building a modern manufacturing stack that functions like software: modular, distributed, and intelligent. This funding will help us strengthen the technologies and capabilities that make on-demand manufacturing possible at scale.”
Vibhore Sharma, Partner at Capital 2B, said, “We invested in Leumas because they are solving a global challenge: manufacturing that is slow, expensive, and hard to scale. Their integration of advanced robotics and intelligent software, along with a delivery model that is easy for brands to adopt, makes them truly differentiated. It is a fundamental reimagining of how factories should operate today.”
Ankit Kedia, Founder and Lead Investor at Capital-A, said, “Modular, software-driven, and built to scale – this is the kind of manufacturing innovation the world needs right now. Leumas delivers it with a rare combination of deep technical expertise and operational clarity. Their approach stands out in industries like pharma and wellness, where speed, compliance, and adaptability are essential. It’s a bold, timely solution to a global challenge and exactly the kind of vision we’re proud to support.”
Ajay Anand, Partner at Anicut Capital, said, “Leumas is showing the world what the future of manufacturing looks like – modular, intelligent, and instantly scalable. With India poised to become a manufacturing leader, Leumas brings the right combination of deep tech and practical execution to help brands scale efficiently.”
